Intuitive Surgical income statement

In fiscal 2025, Intuitive Surgical reported revenue of $10.06bn, up 20.5% on the year before, operating income of $2.95bn (a 29.3% margin) and net income of $2.86bn, or $7.87 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Intuitive Surgical: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	1.1	1.4	1.8	2.2	2.3	2.1	2.4	2.7	3.1	3.7	4.5	4.4	5.7	6.2	7.1	8.4	10.1	11.6
Cost of revenue	0.3	0.4	0.5	0.6	0.7	0.7	0.8	0.8	0.9	1.1	1.4	1.5	1.8	2.0	2.4	2.7	3.4	3.8
Gross profit	0.8	1.0	1.3	1.6	1.6	1.4	1.6	1.9	2.2	2.6	3.1	2.9	4.0	4.2	4.7	5.6	6.6	7.8
Research and development	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.6	0.6	0.7	0.9	1.0	1.1	1.3	1.5
Selling, general and administrative	0.3	0.4	0.4	0.5	0.6	0.7	0.6	0.7	0.8	1.0	1.2	1.2	1.5	1.7	2.0	2.1	2.4	2.6
Operating income	0.4	0.6	0.7	0.9	0.9	0.5	0.7	0.9	1.1	1.2	1.4	1.0	1.8	1.6	1.8	2.3	2.9	3.3
Income before tax	0.4	0.6	0.7	0.9	0.9	0.5	0.8	1.0	1.1	1.3	1.5	1.2	1.9	1.6	2.0	2.7	3.3	3.6
Income tax	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.1	0.2	0.3	0.1	0.3	0.4	0.6
Net income	0.2	0.4	0.5	0.7	0.7	0.4	0.6	0.7	0.7	1.1	1.4	1.1	1.7	1.3	1.8	2.3	2.9	3.0
Diluted EPS	$0.66	$1.05	$1.37	$1.78	$1.86	$1.23	$1.73	$2.09	$1.92	$3.16	$3.85	$2.94	$4.66	$3.65	$5.03	$6.42	$7.87	$8.28
Diluted shares (average)	353m	363m	362m	370m	361m	339m	341m	354m	349m	356m	358m	361m	366m	362m	357m	362m	363m	357m
EBITDA	0.4	0.6	0.7	0.9	0.9	0.6	0.8	1.0	1.1	1.3	1.5	1.3	2.1	1.9	2.1	2.8	3.5	—

US$ millions unless shown otherwise. Fiscal quarters.

Intuitive Surgical: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	2,414	2,253	2,440	2,505	2,866	2,771	2,892	3,049
Cost of revenue	771	796	822	843	962	940	932	964
Gross profit	1,642	1,458	1,618	1,662	1,904	1,831	1,960	2,084
Research and development	295	316	313	329	353	362	371	408
Selling, general and administrative	613	563	561	573	687	613	618	633
Operating income	735	578	743	760	864	855	972	593
Income before tax	810	669	832	855	956	940	1,055	668
Income tax	122	−35	168	146	156	114	231	144
Net income	686	698	658	704	795	822	818	523
Diluted EPS	$1.89	$1.92	$1.81	$1.95	$2.20	$2.28	$2.29	$1.49

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BAX vs ISRG ALC vs ISRG ISRG vs ZBH

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Intuitive Surgical's SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Intuitive Surgical.